Www.england.nhs.uk Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014.

Slides:



Advertisements
Similar presentations
Community Pharmacy Workbook
Advertisements

COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team January 2015.
Pharmacy flu service Presented by Kate Birkenhead Public Health Commissioning Manager NHS England September 2014.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Respiratory illness in children asthma standards of care
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Karen Homan NHS Bedfordshire
 Minor Ailment Service.  Policy To establish community pharmacies as the first port of call for the NHS treatment of common clinical.
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Psnc.org.uk/flu#getreadyforflu Read and delete this slide Alongside the guidance and resources available at psnc.org.uk/flu, PSNC Briefing 053/15 provides.
Repeat Dispensing Sue Carter Regional Tutor Hampshire and IOW 1.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
How can COPD Community Services reduce hospital admissions? Glenda Esmond Respiratory Nurse Consultant West Herts Community COPD Service.
H ALTON, S T H ELENS & K NOWSLEY L OCAL P HARMACEUTICAL C OMMITTEE Advanced Service – Flu What you need to know to run a successful flu service.
Falls Prevention & Inhaler Service Update Training Claire Thomas.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Improving the effectiveness of integrated care teams Rob Darracott Pharmacy Voice.
Community Pharmacy Cheshire & Wirral (CPCW) Helen Murphy Chief Executive Officer Community Pharmacy Cheshire and Wirral.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
Using CQUINS to improve COPD care on discharge from Acute Trust
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Responsible Respiratory Prescribing
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Areas to cover Analysis of information Recruitment Review.
Moving from paper to electronic prescriptions. EPS in a nutshell EPS enables prescriptions to be sent electronically from the GP to the pharmacy ready.
YOUR PHARMACY / JOB- TITLE YOUR NAME Respiratory MUR.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Community Pharmacy: local healthcare Kath Gulson Chief Officer Halton, St Helens and Knowsley Local Pharmaceutical Committee
TACKLING HEALTH INEQUALITIES in PORTSMOUTH Katie Hovenden Director of Professional and Clinical Development NHS Portsmouth CCG.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Read and then delete this slide This PSNC slide deck contains information on community pharmacy and the services it provides It is designed to be used.
Moving from paper to electronic prescriptions
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
The NHS Urgent Medicine Supply Advanced Service Pilot
Medicines Optimisation
Domiciliary MUR – getting started
Dipesh Raghwani and Peter Marks
How to achieve the HLP and asthma quality criteria
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
Barriers to implementing COPD guidelines for non-medical prescribers: a qualitative interview study Alison Paterson1, Anne Kinnear1, Marion Bennie2, Moira.
How Community Pharmacy supports local communities in Brighton and Hove
Monitoring asthma in primary care
NHS Community Pharmacy Contractual Framework
MUR and NMS Respiratory Toolkit.
NMS / MUR referral from Hull and East Yorkshire Hospitals at discharge
Medicines Optimisation
Asthma Annual Reviews Hetal Dhruve Presented by Anh Vu
New Medicines Service(NMS) Maximising Advances Services
Discharge Medication Review (DMR)
12 months before treatment 12 months after treatment
CONDUCTING THE TRIAL AT
Childhood Asthma : Lessons still to be learnt
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Prescribing Update - Respiratory July 2019
Integration of community pharmacy with PCNs
Introduction Project At Crown Street Surgery:
Optimisation of Respiratory MURs and NMS in Community Pharmacy
Point of Dispensing and Counselling Intervention Enhanced Service: Community Pharmacy (PODIS)
Presentation transcript:

Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014

Service Specification

Built upon the MUR/Prescription Intervention advance service Any patient eligible for a Prescription Intervention can be invited to join the scheme Patients newly prescribed an inhaler should receive inhaler technique training via NMS- outside of this project Patients entitled to one PI; one brief intervention; and one MUR in a 12 month period Service Details

Required data and patient consent to be captured on consultation form(s) Information to be entered on to PharmOutcomes Consultation form(s) to be retained in the pharmacy; copy to be sent to patients GP Payment for PI to be claimed via FP34c (£28) Payment for brief intervention generated via PharmOutcomes (£10) Expressions of Interest to provide the scheme to be circulated to contractors shortly Service Details

PREM1 to be submitted to AT (if not previously done) Intervention to take place in the consultation room Telephone interventions are not allowed Offsite consultations are permitted, apply to the AT via the standard NHS England procedure Signed SLA submitted to AT Premises Requirements

Pharmacist Accreditation

Accredited to undertake MURs Undergone face to face inhaler technique training since 2011 Completed the Declaration of Competence for Improving Inhaler Technique through Community Pharmacy Pharmacist requirements

Soon to be launched Pharmacists that have undergone face to face inhaler technique training are able to start and accredit retrospectively Contractors to be informed when DoC available, pharmacists providing the service will have 2 months after launch to complete Copy of DoC to be kept in the pharmacy Declaration of Competence

Top Tips

1.Check the patient’s PMR for frequency of ordering of medication before starting the review. For patients with asthma Ordering more than twelve short-acting reliever inhalers over the last year may indicate poor control and that preventative treatments need to be stepped up. Generally patients with asthma should require thirteen inhaled corticosteroid (ICS) preventer inhalers per year (might be less for 200 dose metered dose inhalers). Is the patient prescribed a long-acting beta 2 agonist (LABA) without an ICS? This requires a review of the regimen. Top Tips for Respiratory MURs

2.What does the patient know about their condition and its treatment? 3.Has the patient had a review before? Who did the review? Does the patient see anyone else for their condition? Explain that the reviews are being done with the knowledge of GP practices in the area and that the aim is to improve medicines use for respiratory conditions. 4.Check adherence with the information from the PMR and document any reasons for non-adherence e.g. difficulty in using device, side-effects, perception of ineffectiveness, lack of knowledge of indications for different inhalers. Does the patient experience any problems taking / using their medicines? Top Tips for Respiratory MURs

5.Assess inhaler technique - use In-check device. Would the patient benefit from a device switch, adding a spacer? Does the patient have the same devices i.e. MDI or Turbohaler? 6.Does the patient know how to take other medicines prescribed for their respiratory condition e.g. rescue packs of corticosteroids / antibiotics, mucolytics or theophylline for COPD. 7.Give smoking cessation advice if appropriate. 8.Does the patient need flu or Pneumococcal vaccination? Top Tips for Respiratory MURs

9.Does the patient have any questions / need more information about their medicines? 10.Refer patients if they report: An increase in exacerbations Their symptoms are not controlled Side-effects of medicines Severe or life-threatening asthma exacerbation Haemoptysis- spitting or coughing up blood Top Tips for Respiratory MURs

Questions? agm.optometry-